IL108694A0 - Farnesyl: protein transferase inhibitors as anticancer agents - Google Patents

Farnesyl: protein transferase inhibitors as anticancer agents

Info

Publication number
IL108694A0
IL108694A0 IL10869494A IL10869494A IL108694A0 IL 108694 A0 IL108694 A0 IL 108694A0 IL 10869494 A IL10869494 A IL 10869494A IL 10869494 A IL10869494 A IL 10869494A IL 108694 A0 IL108694 A0 IL 108694A0
Authority
IL
Israel
Prior art keywords
farnesyl
anticancer agents
protein transferase
transferase inhibitors
alkyl
Prior art date
Application number
IL10869494A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL108694A0 publication Critical patent/IL108694A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015Esters of acyclic unsaturated acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3821Acyclic saturated acids which can have further substituents on alkyl substituted by B, Si, P or a metal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • C07F9/4012Esters of acyclic acids which can have further substituents on alkyl substituted by B, Si, P or a metal

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10869494A 1993-02-23 1994-02-17 Farnesyl: protein transferase inhibitors as anticancer agents IL108694A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2141193A 1993-02-23 1993-02-23

Publications (1)

Publication Number Publication Date
IL108694A0 true IL108694A0 (en) 1994-05-30

Family

ID=21804071

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10869494A IL108694A0 (en) 1993-02-23 1994-02-17 Farnesyl: protein transferase inhibitors as anticancer agents

Country Status (19)

Country Link
US (1) US5463181A (el)
EP (1) EP0686159B1 (el)
JP (1) JPH08509470A (el)
KR (1) KR100305128B1 (el)
CN (1) CN1045207C (el)
AT (1) ATE159023T1 (el)
AU (1) AU684071B2 (el)
CA (1) CA2154871C (el)
DE (1) DE69406110T2 (el)
DK (1) DK0686159T3 (el)
ES (1) ES2110738T3 (el)
FI (1) FI111369B (el)
GR (1) GR3025499T3 (el)
HU (1) HUT72647A (el)
IL (1) IL108694A0 (el)
NO (1) NO306618B1 (el)
NZ (1) NZ262585A (el)
TW (1) TW265345B (el)
ZA (1) ZA941099B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
FR2833266B1 (fr) * 2001-12-11 2004-10-22 Mayoly Spindler Lab Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
EA024559B1 (ru) 2009-05-06 2016-09-30 Лаборэтори Скин Кэа, Инк. Композиции для нанесения на кератинизированную поверхность кожи млекопитающего и способ доставки
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57142993A (en) * 1981-02-28 1982-09-03 Sagami Chem Res Center 2-hydroxyphosphonic diester
DE3313070A1 (de) * 1983-04-12 1984-10-18 Bayer Ag, 5090 Leverkusen Chlorierte phosphorylmethylcarbonyl-derivate, verfahren zu ihrer herstellung und ihre verwendung in pflanzenschutmitteln
DE3425701A1 (de) * 1984-07-12 1986-01-16 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von chlorierten phosphorylmethylcarbonyl-derivaten und neue zwischenprodukte zu ihrer herstellung
US4924024A (en) * 1988-01-11 1990-05-08 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors, new intermediates and method
US5177239A (en) * 1989-07-18 1993-01-05 E. R. Squibb & Sons, Inc. Method for preparing a phosphonic acid ester
US5298655A (en) * 1991-09-27 1994-03-29 Merck & Co., Inc. Farnesyl pyrophosphate analogs

Also Published As

Publication number Publication date
JPH08509470A (ja) 1996-10-08
EP0686159A1 (en) 1995-12-13
HUT72647A (en) 1996-05-28
KR100305128B1 (ko) 2001-11-22
GR3025499T3 (en) 1998-02-27
DE69406110D1 (de) 1997-11-13
ATE159023T1 (de) 1997-10-15
FI953934A (fi) 1995-08-22
NO306618B1 (no) 1999-11-29
AU684071B2 (en) 1997-12-04
CA2154871C (en) 1998-04-07
CN1118166A (zh) 1996-03-06
CA2154871A1 (en) 1994-09-01
DE69406110T2 (de) 1998-05-14
AU6232494A (en) 1994-09-14
TW265345B (el) 1995-12-11
NO953292D0 (no) 1995-08-22
NZ262585A (en) 1997-12-19
US5463181A (en) 1995-10-31
FI111369B (fi) 2003-07-15
CN1045207C (zh) 1999-09-22
HU9502455D0 (en) 1995-10-30
DK0686159T3 (da) 1998-01-26
ES2110738T3 (es) 1998-02-16
ZA941099B (en) 1994-08-30
EP0686159B1 (en) 1997-10-08
NO953292L (no) 1995-08-22
FI953934A0 (fi) 1995-08-22

Similar Documents

Publication Publication Date Title
GB9320782D0 (en) Stabilising of proteins on solution
NZ297157A (en) Amine derivatives with calcium ion receptor activity; medicaments containing such compounds
HU9600697D0 (en) Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
HU9502455D0 (en) Farnesyl:protein transferase inhibitors as anticancer agents
AU683872B2 (en) Polyamine derivatives as radioprotective agents
GR3036754T3 (en) Use of isoxazole- and crotonamide derivatives for the manufacture of a medicament for the treatment of cancers
NZ329853A (en) 4-piperidinyl substituted 2-amino indane derivatives and medicaments
AR247432A1 (es) Agente para la preparacion de fibras y procedimiento para su preparacion
AR247750A1 (es) Sistema inhibidor de polimerizacion y composicion estabilizada que lo comprende.
SE9003704D0 (sv) New selenophen derivatives, a preparation process of the samme and therapeutical compositions containing them
HUP9701382A2 (hu) Új 7,8-dihidro-8-metil-9H-1,3-dioxolo-[4,5-h][2,3]-benzodiazepin-származékok, ilyen hatóanyagot tartalmazó gyógyászati készítmény, és eljárás a hatóanyag előállítására
ES8604532A1 (es) Procedimiento de preparacion de nuevos derivados as-triazinos condensados
NZ240392A (en) Calcium borate/amino carboxylate corrosion inhibitors: coating formulations
CS746285A2 (en) Method of as-triazine's new fussed derivatives preparation
CS743087A2 (en) Herbicide and method of its effective substances production
HUP9902470A2 (hu) Bifenil-szulfonil-amino-alkil-karbonsav-származékok és az ezeket tartalmazó gyógyszerkészítmények